Neuromodulation Research Grant Winners
Funded by Medtronic
Medtronic will not influence the research data or publication content in order to further ensure commercial independence of scientific content and Medtronic is committed to supporting scientific discussion
2021
Glenn Werneburg, Cleveland Clinic
Sacral neuromodulation device biofilm microbial and metabolic composition and association with infection
2020
Zhina Sadeghi, MD, University of Michigan
Impact of Pudendal Nerve Stimulation on the Refractory Underactive Detrusor Patients’ Urinary Symptoms, Health Related and Sexual Quality of Life
2020
Christine Wang, PhD, Stony Brook University
EFFECT OF COMBINED PERCUTANEOUS TIBIAL NERVE STIMULATION AND ACUTE INTERMITTENT HYPOXIA THERAPIES ON REFRACTORY OVERACTIVE BLADDER
2019
A. Lenore Ackerman, MD, PhD, Cedars-Sinai Medical Center
The Role of the GU Microbiota in predicting Responses to Sacral Neuromodulation for Overactive Bladder in Older Women
2019
Ron Ron Cheng, MD, Virginia Mason Medical Center
Leveraging digital health and patient engagement to increase health literacy and improve symptom outcomes in sacral neuromodulation for voiding symptoms
2019
Jacqueline Speed, MD, Stanford University School of Medicine
Determining Patient Preferences in the Treatment of Medication-Refractory Overactive Bladder
2019
Varun Talanki, MD, Stony Brook University
Efficacy of Percutaneous Tibial Nerve Stimulation (PTNS) in the Treatment of Female Sexual Dysfunction
2018
Giulia Lane, MD, University of Michigan, Ann Arbor, MI
Impact of Percutaneous Posterior Tibial Nerve Stimulation on Urinary and Global Quality of Life in Multiple Sclerosis
2018
Jessica Rueb, MD, Cleveland Clinic, Cleveland, OH
Effect of Pulse Width on Efficacy of Sacral Neuromodulation, A Randomized Cross Over Study
2018
Katherine Shapiro, MD, University of Pittsburgh, Pittsburgh, PA
Superficial Peroneal Nerve Neuromodulation for Non-Obstructive Urinary Retention
2017
Tara Cohen, PhD, Cedars-Sinai Medical Center, Los Angeles, CA
Improving Patient Experience with Sacral Neuromodulation: A Human Factors Approach
2017
Evgeniy Kreydin, MD, University of Southern California, Los Angeles, CA
Characterization of Brain Activity During the Micturition Cycle
2017
Shannon Wallace, MD, Stanford University, Stanford, CA
Optogenetic Neuromodulation in the Diabetic Cystopathy Rat Model
2016
Dennis Bourbeau, PhD, MetroHealth, Cleveland, OH
AUTOMATED CLOSED-LOOP STIMULATION TO INHIBIT NEUROGENIC BLADDER OVERACTIVILTY
2016
Robert Kelley, Emory University, Atlanta, GA
ELECTROPHYSIOLOGIC MAPPING OF THE URINARY BLADDER
2016
Justina Tam, Stony Brook Medicine, Stony Brook, NY
EFFECT OF PERCUTANEOUS TIBIAL NEUROMODULATION WITH THE NURO SYSTEM ON BRAIN ACTIVITY
2015
Javier Pizarro-Berdichevky, Cleveland Clinic
NON-HEAD 1.5 TESLA MRI COMPATIBILITY WITH SACRAL NEUROMODULATION
2015
Blayne Welk, Western University
A RANDOMIZED TRIAL OF TRANSCUTANEOUS NERVE STIMULATION FOR NEUROGENIC BLADDER PATIENTS
2015
Dominique Malacarne, New York University Medical Center
RANDOMIZED CONTROLLED TRIAL OF PTNS VERSUS SHAM EFFICACY IN TREATMENT OF BLADDER PAIN SYNDROME
2014
Daniel Paul Casella, Fellow, Vanderbilt University
MODULATION OF THE RAT MICTURITION REFLEX WITH TRANSCUTANEOUS ULTRASOUND
2014
Steven Weissbart and Ariana Smith, Fellow, University of Pennsylvania
CHANGES IN BRAIN FMRI IN WOMEN WITH OVERACTIVE BLADDER TREATED SACRAL NEURMODULATION
2014
Yahir Santiago-Lastra, Fellow, University of Michigan
COMPARATIVE EFFECTIVENESS OF SACRAL NEUROMODULATION AND PERCUTANEOUS TIBIAL NERVE STIMULATION
2014
Kevin Gioia, Fellow, Virginia Mason
DETERMINE WHETHER INTRAOPERATIVE AMPLITUDE AND OPTIMAL LEAD PLACEMENT ARE ASSOCIATED WITH IMPROVED OUTCOMES FOR SACRAL NEUROMODULATION
2013
Megan Bing, MD, University of Iowa
SACRAL NEUROMODULATION AND CYTOKINES: AN INVESTIGATION INTO INTERSTITIAL CYSTITIS
2013
Gene Huang, MD, LOMA Linda University
INTERMITTENT VERSUS CONTINUOUS STIMULATION IN BILATERAL INTERSTIM IMPLANTATION FOR OVERACTIVE BLADDER
2013
Forrest Jellison, MD, UCLA
UNILATERAL VERSUS BILATERAL SACRAL NEUROMODULATION FOR IDIOPATHIC REFRACTORY OVERACTIVE BLADDER